Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Sandoz Group Ag (SDZNY)

Sandoz Group Ag (SDZNY)
40.1050 +0.3850 (+0.97%) 15:51 ET [OTC US]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
40.0200
Day High
40.6000
Open 40.2800
Previous Close 39.7200 39.7200
Volume 14,952 14,952
Avg Vol 50,550 50,550
Stochastic %K 70.99% 70.99%
Weighted Alpha +10.77 +10.77
5-Day Change -0.4150 (-1.02%) -0.4150 (-1.02%)
52-Week Range 32.4800 - 49.8099 32.4800 - 49.8099
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 17,476,800
  • Shares Outstanding, K 440,000
  • Annual Sales, $ 10,384 M
  • Annual Income, $ 1,000 K
  • EBIT $ 0 M
  • EBITDA $ 307 M
  • 60-Month Beta 0.41
  • Price/Sales 1.71
  • Price/Cash Flow 15.05
  • Price/Book 2.17
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 06/04/25
  • Annual Dividend & Yield 0.70 (1.77%)
  • Most Recent Dividend 0.405 on 04/22/25
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.6100 +12.62%
on 04/07/25
Period Open: 43.0600
43.8100 -8.46%
on 03/25/25
-2.9550 (-6.86%)
since 03/21/25
3-Month
35.6100 +12.62%
on 04/07/25
Period Open: 47.0000
49.8099 -19.48%
on 02/14/25
-6.8950 (-14.67%)
since 01/23/25
52-Week
32.4800 +23.48%
on 04/26/24
Period Open: 33.5800
49.8099 -19.48%
on 02/14/25
+6.5250 (+19.43%)
since 04/23/24

Most Recent Stories

More News
Zacks Industry Outlook Dr. Reddy's, Sandoz and Teva Pharmaceuticals

For Immediate ReleaseChicago, IL – April 16, 2025 – Today, Zacks Equity Research Equity are Dr. Reddy’s Laboratories RDY, Sandoz SDZNY and Teva Pharmaceuticals TEVA.Industry: Generic DrugsLink: https://www.zacks.com/commentary/2448907/3-generic-drug-stocks-to-watch-amid-trade-war-jitters-inflation-woesWhile...

SDZNY : 40.1050 (+0.97%)
RDY : 13.68 (-1.44%)
TEVA : 14.29 (+2.07%)
3 Generic Drug Stocks to Watch Amid Trade War Jitters & Inflation Woes

While 2025 began on a positive note for the pharmaceutical industry, things have taken a sharp turn amid escalating fears of a global trade war. While Trump had initially exempted pharmaceuticals from...

SDZNY : 40.1050 (+0.97%)
RDY : 13.68 (-1.44%)
TEVA : 14.29 (+2.07%)
Intra-Cellular Therapies Stock Up 34% on J&J's $14.6B Buyout Offer

Intra-Cellular Therapies ITCI signed a definitive agreement with pharma bigwig Johnson & Johnson JNJ. Per the terms, the pharma giant will acquire all outstanding shares of ITCI for $132 per share in cash,...

ITCI : 131.87 (-0.04%)
SDZNY : 40.1050 (+0.97%)
JNJ : 155.38 (-1.50%)
Why Coherus Biosciences Popped Today

Coherus is divesting its non-core ophthalmology franchise.

SDZNY : 40.1050 (+0.97%)
CHRS : 1.1100 (+1.83%)
Eli Lilly, McKesson, Novartis Flash Promising Chart Action

Eli Lilly, McKesson, and Novartis are catching investors' attention with promising chart patterns and revenue growth, signaling potential buying opportunities.

MCK : 692.27 (-0.42%)
SDZNY : 40.1050 (+0.97%)
COR : 284.71 (-0.54%)
LLY : 829.42 (+0.23%)
NVS : 110.13 (-1.15%)
CAH : 134.43 (+0.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Sandoz Group AG develops, manufactures and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars and biotechnology manufacturing services and anti-infectives, such as active pharmaceutical...

See More

Key Turning Points

3rd Resistance Point 42.9000
2nd Resistance Point 41.6000
1st Resistance Point 40.6600
Last Price 40.1050
1st Support Level 38.4200
2nd Support Level 37.1200
3rd Support Level 36.1800

See More

52-Week High 49.8099
Fibonacci 61.8% 43.1899
Fibonacci 50% 41.1450
Last Price 40.1050
Fibonacci 38.2% 39.1000
52-Week Low 32.4800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective